Bold approaches to treat and cure genetic diseases
Emugen Therapeutics LLC is a discovery research company developing revolutionary treatments for patients with genetic disorders
Breakthrough discovery to accelerate therapeutic development:
Emugen Therapeutics LLC is a discovery research company developing revolutionary treatments for patients with genetic disorders. At Emugen, our team is leveraging novel genetic and chemogenetic technologies to develop safe and effective gene therapies for genetic disorders.
Collaborative, innovative, and risk-taking research:
Brain disorders are a leading contributor to the global burden of disease, yet there are no effective treatments for millions of patients living with neurological and psychiatric disorders. A major obstacle to progress in developing therapeutics has been the failure of translating treatments successfully developed in mice to successful human clinical trials. To address this considerable unmet need, Emugen’s innovative discovery engine is leveraging our founders’ world-renowned expertise in brain science, genetic engineering, animal models, gene therapy and brain disorders to advance a novel pipeline of gene therapies for clinical applications.
Empowering Emugen's discovery engine:
Emugen is building the industry’s most comprehensive pre-clinical research model development, genetic engineering techonologies, and testing platform--providing in-house support to our internal discovery engine and partnerships/services to pharma, biotech, and non-profit clients (including, but not limited to, genome editing in multiple models, biomarker studies, gene therapy efficacy and safety studies, and behavioral, cognitive, and neurophysiological testing).
An inclusive research community:
Emugen is an equal-opportunity employer committed to promoting diversity, equity, and inclusion in both our workplace and our community. We maintain a collaborative and supportive environment where our employees’ voices are heard, and their opinions are valued.